You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Robot-Assisted Cognitive Training for Socially Isolated Older Adults with Mild Cognitive Impairment
SBC: Applied Universal Dynamics, Corp. Topic: NIAThis project will develop a Socially-Assistive Robot (SAR) to provide cognitive training, in the form of learning to play the piano, to improve cognitive functioning and reduce feelings of loneliness in socially-isolated older adults. The SAR will administer cognitive training via guided practice on a set of standard piano lesson tasks designed to reflect particular cognitive functions: memory, at ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Commercial Readiness for Direct-to-Digital Pathology
SBC: APPLIKATE TECHNOLOGIES, INC. Topic: NCIAbstract Project Summary Applikate Technologies has developed Clearing Histology with Multiphoton Microscopy (CHiMP), a novel tissue processing and imaging platform that provides direct-to-digital images from intact pathology tissue specimens, such as biopsies, without the need for wax embedding, slicing, or scanning of slides. The application of this technology to cancer diagnosis will reduce err ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Social Assistive Robot Interface for People with Alzheimer's and Other Dementias to Aid in Care Management
SBC: ADVANCED MEDICAL ELECTRONICS CORP Topic: NIAProject Summary/Abstract Advanced Medical Electronics Corporation and our partners propose to develop a Socially-Assistive Robot (SAR) system for persons with dementia (PWD),(mild cognitive impairment, Alzheimerandapos;s disease, or other dementias), who are living in assisted living facilities. The proposed system uses Augmented Intelligence (AI) to communicate with the PWD in natural language. T ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Islet culture, shipping, and infusion device
SBC: WILSON WOLF MANUFACTURING CORPORATION Topic: N/ADESCRIPTION (provided by applicant): The culture and shipment of islets are an integral part of islet transplant research. Flasks, petri dishes, and bags are the devices used to perform that role. However, these devices have inherent design characteristics that make them poorly suited to the unique needs of islet culture and islet shipping. This results in the use of far too many devices to maint ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
Arterial-Mimetic Grafts Molded from Purified Proteins
SBC: Gel-Del Technologies, Inc. Topic: N/ADESCRIPTION (provided by applicant): Peripheral artery disease and trauma are leading causes of morbidity and amputation in the United States. Recent advances in biomaterials provide for potential development of small diameter vascular grafts as a life-saving treatment. Development of a life-long graft (lt 6 mm id) requires a construct that will not cause significant blood clotting/thrombosis and ...
SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health -
Photodynamic Treatment of Endotracheal Tube Biofilms
SBC: Advanced Photodynamic Technologies, Inc. Topic: N/ADESCRIPTION (provided by applicant): Ventilator-associated pneumonia (VAP) is a common, significant, life threatening and unaddressed infectious disease problem that occurs in patients who are intubated with an endotracheal tube and require mechanical ventilation. Of the l .6 million patients per year in the US who require mechanical ventilation, 15-25% will develop VAP and 24-71% will die of th ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Analgesic Drug for Local Delivery by Fluoroscopy
SBC: INTERVENTIONAL ANALGESIX INC. Topic: 106Chronic pain affects 116 million Americans at a cost of $560 billion per year according to the Institute of Medicine. 25.3 million adults had pain every day for the preceding 3 months. Current analgesic therapies often fail in chronic pain and can lead to drug abuse. 18,893 Americans died from prescription opioids in 2014, 1.9 million were addicted to them. The enclosed application develops a non- ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Implantable Unpinning Termination Therapy for Cardiac Arrhythmias
SBC: National Biomedical LLC Topic: NHLBIProject Summary/Abstract We propose the development and evaluation of a novel implantable low-energy device, using an innovative low-energy multi-pulse therapy, to achieve well-tolerated treatment of ventricular and atrial tachyarrhythmias. Ventricular arrhythmias (VAs) including ventricular tachycardia (VT) and ventricular fibrillation (VF) are responsible for 75-80% of Sudden Cardiac Death (SCD) ...
SBIR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health -
Path to Commercialization ofthe first "off the shelf" T cell product
SBC: ViraCyte LLC Topic: NHLBIABSTRACT The adoptive transfer of virus specific T cells has produced remarkable clinical results in patients with viral diseaseHoweverbroader implementation of this therapy has been limited by theiprohibitive production costsiicomplexity of manufactureiiiprolonged time for preparation and product releaseandivthe requirement for individualizedpatient specific productsOver the pastyears we have sys ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
SBC: Mabloc, LLC Topic: NIAIDAbstract PROJECT SUMMARY/ABSTRACT The recent groundbreaking experiment using a single neutralizing monoclonal antibody (nmAb) to reduce the death rate in Ebola virus (EBOV)-infected individuals highlights the importance of this class of drug in the treatment of infectious disease. In August 2019, Dr. Anthony Fauci announced that administration of mAb114 had reduced the death rate from 70% to appro ...
STTR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health